English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5208]
News [15387]
Articles [108]
Editorials [3]
Conferences [263]
elearning [21]
MLN9708 in combination with lenalidomide and dexamethasone
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
MLN9708 in combination with lenalidomide and dexamethasone ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
16 Dec 2012
History of epidermal stem cell use in the clinical setting
Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy
History of epidermal stem cell use in the clinical setting ( Prof Michele De Luca - University of Modena e Reggio Emilia, Modena, Italy )
14 Dec 2012
Effects of obesity in breast cancer patients
Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA
Effects of obesity in breast cancer patients ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )
14 Dec 2012
The AZURE translational study
Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
The AZURE translational study ( Prof Robert Coleman	 - Weston Park Hospital, University of Sheffield, UK )
14 Dec 2012
Diagnosis of blood cancer after a breast cancer diagnosis
Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA
Diagnosis of blood cancer after a breast cancer diagnosis ( Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA )
14 Dec 2012
HDAC inhibition sensitises triple-negative breast cancer cells to PARP...
Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA
HDAC inhibition sensitises triple-negative breast cancer cells to PARP inhibition ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )
13 Dec 2012
Neratinib shows beneficial effects in the treatment of HER2 mutated breast...
Prof Ron Bose – Washington University School of Medicine, St. Louis, USA
Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer ( Prof Ron Bose – Washington University School of Medicine, St. Louis, USA )
12 Dec 2012
Breast cancer genome sequencing identified HER2 mutations as targets for drug...
Prof Ron Bose - Washington University School of Medicine, St Louis, USA
Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment ( Prof Ron Bose - Washington University School of Medicine, St Louis, USA )
12 Dec 2012
Cognitive problems may be present before chemotherapy in women with breast...
Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor...
Cognitive problems may be present before chemotherapy in women with breast cancer ( Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA )
12 Dec 2012
Potential targets and complications of apoptosis and necrosis
Dr Doug Green – St Jude Children’s Research Hospital, Memphis, USA
Potential targets and complications of apoptosis and necrosis ( Dr Doug Green – St Jude Children’s Research Hospital, Memphis, USA )
7 Dec 2012
Prognostic signatures in colon cancer
Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain
Prognostic signatures in colon cancer ( Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain )
7 Dec 2012
Targeting the proteasome mechanism
Dr Stig Linder – Karolinska Institute, Stockholm, Sweden
Targeting the proteasome mechanism ( Dr Stig Linder – Karolinska Institute, Stockholm, Sweden )
7 Dec 2012
<1…406407408409410…434>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top